• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强MRI肝胆期具有非典型强化特征和低信号的小(≤3厘米)肝脏病变在肝硬化中的特征:一篇符合STARD标准的文章

Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.

作者信息

Shin Seung Kak, Kim Yun Soo, Choi Seung Joon, Shim Young Sup, Jung Dong Hae, Kwon Oh Sang, Choi Duck Joo, Kim Ju Hyun

机构信息

Department of Internal medicine Department of Radiology Department of Pathology, Gachon University Gil Medical Center, Incheon, Republic of Korea.

出版信息

Medicine (Baltimore). 2017 Jul;96(29):e7278. doi: 10.1097/MD.0000000000007278.

DOI:10.1097/MD.0000000000007278
PMID:28723741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5521881/
Abstract

It is difficult to characterize the nodular lesions in cirrhotic liver if typical enhancement pattern is not present on dynamic contrast-enhanced imagings. Although the signal intensity of the hepatobiliary phase in gadoxetic acid-enhanced magnetic resonance imaging (MRI) is helpful for characterization of the lesions, some dysplastic nodules may also exhibit low signal intensity in the hepatobiliary phase. We aimed to assess the usefulness of gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI including diffusion-weighted imaging (DWI) for differentiation between atypical small hepatocellular carcinomas (HCCs) and dysplastic nodules showing low signal intensity (SI) in the hepatobiliary phase, and to evaluate the MRI findings in determining the histological grade of atypical HCCs in patients with cirrhosis.A total of 43 cirrhotic patients with a small (≤3 cm) liver nodule (n = 25, HCC; n = 18, dysplastic nodule) who underwent Gd-EOB-DTPA-enhanced MRI and pathologic confirmation were retrospectively reviewed. Atypical HCC was defined as not showing arterial hyperenhancement and delayed washout on dynamic MRI.High SI on both T2WI and DWI (sensitivity 80.0%, specificity 100%, positive predictive value 100%, negative predictive value 78.3%) was the most specific feature to differentiate atypical HCCs from dysplastic nodules. High SI on both T2WI and DWI (100% vs 61.5%, P = .039) or low SI on pre-enhanced T1WI (83.3% vs 30.8%, P = .021) was more frequent observed in Edmonson grade II-III HCCs compared with those in grade I HCCs.The combination of DWI and T2WI is most useful for the differentiation of atypical small HCCs from dysplastic nodules showing low SI in the hepatobiliary phase. Combination of DWI and T2WI or pre-enhanced T1WI seems to be useful for predicting the histological grade of atypical HCCs.

摘要

如果动态对比增强成像上不存在典型的强化模式,那么对肝硬化肝脏中的结节性病变进行特征性描述就很困难。尽管钆塞酸增强磁共振成像(MRI)中肝胆期的信号强度有助于病变的特征性描述,但一些发育异常结节在肝胆期也可能表现为低信号强度。我们旨在评估钆塞酸(Gd-EOB-DTPA)增强MRI(包括扩散加权成像(DWI))对于鉴别非典型小肝细胞癌(HCC)和在肝胆期表现为低信号强度(SI)的发育异常结节的有用性,并评估MRI表现对确定肝硬化患者中非典型HCC组织学分级的作用。对43例接受了Gd-EOB-DTPA增强MRI检查并经病理证实的肝硬化患者(肝脏有一个小(≤3 cm)结节,其中25例为HCC,18例为发育异常结节)进行了回顾性分析。非典型HCC定义为在动态MRI上未表现出动脉期高增强和延迟消退。T2WI和DWI上均为高信号强度(敏感性80.0%,特异性100%,阳性预测值100%,阴性预测值78.3%)是区分非典型HCC和发育异常结节的最具特异性的特征。与Edmonson I级HCC相比,Edmonson II-III级HCC在T2WI和DWI上均为高信号强度(100%对61.5%,P = 0.039)或增强前T1WI上为低信号强度(83.3%对30.8%,P = 0.021)更为常见。DWI和T2WI的联合对于鉴别在肝胆期表现为低SI的非典型小HCC和发育异常结节最为有用。DWI与T2WI或增强前T1WI的联合似乎有助于预测非典型HCC的组织学分级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fb/5521881/169cf94efa3d/medi-96-e7278-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fb/5521881/82f25846d19d/medi-96-e7278-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fb/5521881/36ae0e8a3314/medi-96-e7278-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fb/5521881/169cf94efa3d/medi-96-e7278-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fb/5521881/82f25846d19d/medi-96-e7278-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fb/5521881/36ae0e8a3314/medi-96-e7278-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32fb/5521881/169cf94efa3d/medi-96-e7278-g006.jpg

相似文献

1
Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.钆塞酸二钠增强MRI肝胆期具有非典型强化特征和低信号的小(≤3厘米)肝脏病变在肝硬化中的特征:一篇符合STARD标准的文章
Medicine (Baltimore). 2017 Jul;96(29):e7278. doi: 10.1097/MD.0000000000007278.
2
Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.钆塞酸增强肝胆期 MRI 和高 b 值扩散加权成像在慢性肝病患者中鉴别高分化肝细胞癌与良性结节
AJR Am J Roentgenol. 2011 Nov;197(5):W868-75. doi: 10.2214/AJR.10.6237.
3
The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.钆塞酸二钠增强磁共振成像在鉴别钆喷酸葡胺增强磁共振图像上具有非典型强化的肝硬化结节中的价值。
PLoS One. 2017 Mar 29;12(3):e0174594. doi: 10.1371/journal.pone.0174594. eCollection 2017.
4
Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.使用钆塞酸二钠增强磁共振成像和扩散加权磁共振成像对肝炎后肝硬化患者小肝细胞癌(≤2.0 cm)诊断标准的验证
Acta Radiol. 2013 Mar 1;54(2):127-36. doi: 10.1258/ar.2012.120262. Epub 2012 Nov 12.
5
Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.钆塞酸增强磁共振成像及扩散加权成像在酒精性肝硬化患者中鉴别高血供增生结节与小(<3 cm)高血供肝细胞癌的价值:一项回顾性病例对照研究
J Magn Reson Imaging. 2020 Jan;51(1):70-80. doi: 10.1002/jmri.26768. Epub 2019 May 6.
6
Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.钆塞酸 MRI 和扩散加权成像在诊断肝细胞癌早期复发中的性能。
Eur Radiol. 2020 Jan;30(1):186-194. doi: 10.1007/s00330-019-06351-0. Epub 2019 Aug 1.
7
Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.扩散加权磁共振成像在肝硬化肝脏中肝细胞癌和发育异常结节特征描述中的作用
J Comput Assist Tomogr. 2010 Jul;34(4):506-12. doi: 10.1097/RCT.0b013e3181da3671.
8
Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.CT 和 MRI 鉴别肝胆期增强 MRI 显示高信号的肝细胞癌与局灶性结节增生。
AJR Am J Roentgenol. 2018 Aug;211(2):347-357. doi: 10.2214/AJR.17.19341. Epub 2018 Apr 30.
9
The utility of gadoxetic acid-enhanced MR imaging to characterize atypical cirrhotic nodules detected on dynamic CT images.钆塞酸二钠增强磁共振成像在对动态CT图像上检测到的非典型肝硬化结节进行特征性诊断中的应用。
PLoS One. 2014 Oct 13;9(10):e107869. doi: 10.1371/journal.pone.0107869. eCollection 2014.
10
Evolution of indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients.肝硬化患者 Gd-EOB-DPTA 增强 MRI 下不定型肝细胞结节的演变。
Radiol Med. 2018 Jul;123(7):489-497. doi: 10.1007/s11547-018-0873-8. Epub 2018 Mar 15.

引用本文的文献

1
Imaging of the Liver and Pancreas: The Added Value of MRI.肝脏和胰腺的影像学检查:磁共振成像的附加价值
Diagnostics (Basel). 2024 Mar 26;14(7):693. doi: 10.3390/diagnostics14070693.
2
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.磁共振成像在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD014798. doi: 10.1002/14651858.CD014798.pub2.
3
Diagnostic efficacy of dynamic liver imaging using qualitative diagnostic algorithm versus LI-RADS v2018 lexicon for atypical versus classical HCC lesions: A decade of experience from a tertiary liver institute.

本文引用的文献

1
Histological grade of hepatocellular carcinoma predicted by quantitative diffusion-weighted imaging.基于定量扩散加权成像预测肝细胞癌的组织学分级
Int J Clin Exp Med. 2015 Mar 15;8(3):4164-9. eCollection 2015.
2
Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis.超声造影用于鉴别肝硬化中不典型小肝细胞癌与发育异常结节
Dig Liver Dis. 2015 Sep;47(9):775-82. doi: 10.1016/j.dld.2015.05.001. Epub 2015 May 13.
3
Treatment of hepatocellular carcinoma: Steps forward but still a long way to go.
使用定性诊断算法与LI-RADS v2018词典对非典型与典型肝癌病变进行动态肝脏成像的诊断效能:来自一家三级肝脏研究所的十年经验。
Eur J Radiol Open. 2020 Feb 12;7:100219. doi: 10.1016/j.ejro.2020.100219. eCollection 2020.
4
Differentiation of Small Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Liver: Texture Analysis Based on MRI Improved Performance in Comparison Over Gadoxetic Acid-Enhanced MR and Diffusion-Weighted Imaging.肝硬化肝脏中微小肝细胞癌与发育异常结节的鉴别:基于MRI的纹理分析在与钆塞酸增强磁共振成像和扩散加权成像比较时性能得到改善。
Front Oncol. 2020 Jan 10;9:1382. doi: 10.3389/fonc.2019.01382. eCollection 2019.
5
Diagnosis of Pre-HCC Disease by Hepatobiliary-Specific Contrast-Enhanced Magnetic Resonance Imaging: A Review.肝胆特异性对比增强磁共振成像诊断 Pre-HCC 疾病:综述。
Dig Dis Sci. 2020 Sep;65(9):2492-2502. doi: 10.1007/s10620-019-05981-0. Epub 2019 Dec 5.
6
Microvascular Invasion in HCC: The Molecular Imaging Perspective.肝细胞癌中的微血管侵犯:分子影像学视角。
Contrast Media Mol Imaging. 2018 Oct 4;2018:9487938. doi: 10.1155/2018/9487938. eCollection 2018.
7
MR with Gd-EOB-DTPA in assessment of liver nodules in cirrhotic patients.钆塞酸二钠增强磁共振成像在评估肝硬化患者肝脏结节中的应用
World J Hepatol. 2018 Jul 27;10(7):462-473. doi: 10.4254/wjh.v10.i7.462.
8
CT-MRI LI-RADS v2017: A Comprehensive Guide for Beginners.《CT-MRI肝脏影像报告和数据系统(LI-RADS)2017版:初学者综合指南》
J Clin Transl Hepatol. 2018 Jun 28;6(2):222-236. doi: 10.14218/JCTH.2017.00062. Epub 2018 Feb 22.
肝细胞癌的治疗:虽有进展,但仍任重道远。
World J Hepatol. 2015 Mar 27;7(3):566-74. doi: 10.4254/wjh.v7.i3.566.
4
CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.肝细胞癌的CT与MR成像诊断及分期:第一部分。发生、生长与扩散:关键病理及成像要点
Radiology. 2014 Sep;272(3):635-54. doi: 10.1148/radiol.14132361.
5
The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase.钆塞酸二钠在肝脏疾病磁共振成像诊断中的应用:重点在肝胆期。
Clin Mol Hepatol. 2013 Dec;19(4):360-6. doi: 10.3350/cmh.2013.19.4.360. Epub 2013 Dec 28.
6
Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging.鉴别发育不良结节与早期肝细胞癌:常规磁共振成像的应用。
World J Gastroenterol. 2013 Nov 14;19(42):7433-9. doi: 10.3748/wjg.v19.i42.7433.
7
Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis.恩替卡韦治疗可减少肝硬化慢性乙型肝炎患者的肝脏事件和死亡。
Hepatology. 2013 Nov;58(5):1537-47. doi: 10.1002/hep.26301. Epub 2013 Sep 30.
8
Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI.钆塞酸增强 MRI 鉴别早期肝细胞癌与良性肝细胞结节。
Br J Radiol. 2012 Oct;85(1018):e837-44. doi: 10.1259/bjr/13212920. Epub 2012 May 2.
9
Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.钆塞酸增强肝胆期 MRI 和高 b 值扩散加权成像在慢性肝病患者中鉴别高分化肝细胞癌与良性结节
AJR Am J Roentgenol. 2011 Nov;197(5):W868-75. doi: 10.2214/AJR.10.6237.
10
Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.早期肝细胞癌的影像学研究:钆塞酸增强磁共振成像的作用。
Radiology. 2011 Dec;261(3):834-44. doi: 10.1148/radiol.11101840. Epub 2011 Oct 13.